THE MODULATION OF PROTEIN-KINASE-C ACTIVITY BY MEMBRANE LIPID BILAYER STRUCTURE

被引:0
|
作者
SLATER, SJ [1 ]
KELLY, MB [1 ]
TADDEO, FJ [1 ]
HO, CJ [1 ]
RUBIN, E [1 ]
STUBBS, CD [1 ]
机构
[1] THOMAS JEFFERSON UNIV, DEPT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hypothesis that protein kinase C (PKC) activity is sensitive to phospholipid head group interactions was tested using lipid bilayers of defined composition with PKC purified from rat brain. The head group interactions were modulated by varying phosphatidylcholine cis-unsaturation, vesicle curvature, and by the addition of phosphatidylethanolamine and cholesterol. With unilamellar vesicles (including 20 mol % brain phosphatidylserine), increased phosphatidylcholine unsaturation potentiated basal and phorbol ester stimulated PKC activity. By contrast, in the presence of phosphatidylethanolamine, the activity decreased with increasing phosphatidylcholine unsaturation. Weakening phospholipid head group interactions spaces the head group region and increases interstitial water, and this effect was assessed from its effect on the fluorescence intensity of the phospholipid-labeled fluorophore 1-palmitoyl-2-N(4- nitrobenzo-2-oxa-1,3-diazole)aminohexanoylphosphatidylcholine (C-6-NBD-PC). When the PKC activities with vesicles of varying phosphatidylcholine unsaturation, with and without phosphatidylethanolamine, were plotted as a function of the fluorescence intensity of C6NBD-PC-labeIed vesicles, a biphasic profile was obtained, which had an optimum value of intensity, relating to head group spacing, that corresponded to a maximal enzyme activity. A similar biphasic curve was also found when PKC activities were plotted as a function of published bilayer intrinsic curvature x-ray diffraction data, a parameter closely related to head group spacing. By contrast, no simple relationship was evident between PKC activity and 1,6-diphenyl-1,3,5-hexatriene anisotropy, taken as a measure of Lipid order or fluidity. Therefore, increasing the level of phosphatidylcholine unsaturation, phosphatidylethanolamine, or cholesterol either potentiates or attenuates PKC activity, dependent on whether the initial condition is above or below its optimum.
引用
收藏
页码:4866 / 4871
页数:6
相关论文
共 50 条
  • [1] EFFECTS OF TPA ON SUBCELLULAR-LOCALIZATION OF PROTEIN-KINASE-C AND LIPID BILAYER STRUCTURE
    LEWIS, BA
    DAWSON, WD
    COOK, JS
    BIOPHYSICAL JOURNAL, 1986, 49 (02) : A153 - A153
  • [2] MODULATION OF PROTEIN-KINASE-C ACTIVITY BY AMIODARONE AND DESETHYLAMIODARONE
    VIG, PJS
    DESAIAH, D
    NEUROTOXICOLOGY, 1991, 12 (03) : 595 - 601
  • [3] REGULATION OF THE STRUCTURE AND FUNCTION OF PROTEIN-KINASE-C BY LIPID
    NEWTON, AC
    ORR, JW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 68 - 68
  • [4] DUAL MODULATION OF PROTEIN-KINASE-C ACTIVITY BY SPHINGOSINE
    SENISTERRA, G
    EPAND, RM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) : 635 - 640
  • [5] DEPENDENCE OF PROTEIN-KINASE-C ACTIVATION BY DIACYLGLYCEROLS AND CALCIUM ON LIPID-MEMBRANE STRUCTURE
    ZIDOVETZKI, R
    LESTER, DS
    BORCHARDT, DB
    GOLDBERG, EM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 43 - 43
  • [6] MODULATION OF PROTEIN-KINASE-C ACTIVITY BY PALMITOYL ESTERS OF MALTOSE
    BENREZZAK, O
    NIGAM, VN
    CANCER BIOCHEMISTRY BIOPHYSICS, 1992, 13 (01): : 13 - 22
  • [7] LIPID ACTIVATORS OF PROTEIN-KINASE-C
    CHAUHAN, VPS
    CHAUHAN, A
    DESHMUKH, DS
    BROCKERHOFF, H
    LIFE SCIENCES, 1990, 47 (12) : 981 - 986
  • [8] LIPID ACTIVATION OF PROTEIN-KINASE-C
    BELL, RM
    BURNS, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (08) : 4661 - 4664
  • [9] ROLE OF MEMBRANE DEFECTS IN THE REGULATION OF THE ACTIVITY OF PROTEIN-KINASE-C
    SENISTERRA, G
    EPAND, RM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 300 (01) : 378 - 383
  • [10] Membrane structure modulation, protein kinase Cα activation, and anticancer activity of Minerval
    Martínez, J
    Vögler, O
    Casas, J
    Barceló, F
    Alemany, R
    Prades, J
    Nagy, T
    Baamonde, C
    Kasprzyk, PG
    Terés, S
    Saus, C
    Escribá, PV
    MOLECULAR PHARMACOLOGY, 2005, 67 (02) : 531 - 540